EMEA-000342-PIP01-08-M07
Key facts
Invented name |
Sutent
|
Active substance |
sunitinib
|
Therapeutic area |
Oncology
|
Decision number |
P/0147/2018
|
PIP number |
EMEA-000342-PIP01-08-M07
|
Pharmaceutical form(s) |
Capsule, hard
|
Condition(s) / indication(s) |
Treatment of gastro-intestinal stromal tumours
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Pfizer Limited
Tel. +44 (0)1034 646607
E-mail: pip_enquiries@pfizer.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000342-PIP01-08-M07
|
Compliance opinion date |
29/06/2018
|
Compliance outcome |
positive
|